Table 2.
Kaplan-Meier 10- and 15-year survival data with 95% CI for all THRs, cemented THR, uncemented THR, hybrid THR, and reverse hybrid THR by country. The 7.3-year survival of reverse hybrid THR in Denmark was 92.8% (95% CI: 90.3–94.7)
| THR Country | No. of THRs | No. of revisions | 10-year survival |
15-year survival |
||
|---|---|---|---|---|---|---|
| (%) | 95% CI | (%) | 95% CI | |||
| All | ||||||
| Denmark | 92,078 | 5,167 | 92.1 | 91.8–92.3 | 86.3 | 85.7–86.9 |
| Sweden | 180,839 | 7,471 | 94.2 | 94.0–94.3 | 88.0 | 87.6–88.3 |
| Norway | 86,076 | 4,656 | 92.8 | 92.6–93.1 | 86.9 | 86.4–87.4 |
| Finland | 79,740 | 5,556 | 90.9 | 90.6–91.1 | 83.5 | 82.9–84.1 |
| Cemented | ||||||
| Denmark | 34,003 | 1,896 | 93.1 | 92.7–93.4 | 87.9 | 87.2–88.6 |
| Sweden | 152,024 | 5,970 | 94.6 | 94.4–94.8 | 89.0 | 88.6–89.4 |
| Norway | 60,957 | 3,171 | 93.4 | 93.1–93.6 | 88.8 | 88.2–89.3 |
| Finland | 31,331 | 2,002 | 92.0 | 91.6–92.4 | 86.6 | 85.7–87.4 |
| Uncemented | ||||||
| Denmark | 37,098 | 1,734 | 92.4 | 91.9–92.9 | 86.0 | 84.5–87.3 |
| Sweden | 13,552 | 582 | 91.7 | 90.8–92.6 | 82.7 | 80.5–84.7 |
| Norway | 13,208 | 946 | 91.0 | 90.3–91.7 | 80.6 | 79.0–82.1 |
| Finland | 38,082 | 2,742 | 90.0 | 89.5–90.4 | 80.8 | 79.9–81.8 |
| Hybrid | ||||||
| Denmark | 20,170 | 1,485 | 90.5 | 90.0–91.0 | 83.8 | 82.5–85.0 |
| Sweden | 5,684 | 613 | 90.2 | 89.3–91.0 | 80.0 | 78.2–81.7 |
| Norway | 2,827 | 274 | 90.6 | 89.2–91.8 | 82.2 | 79.6–84.4 |
| Finland | 7,641 | 598 | 91.0 | 90.2–91.8 | 84.5 | 82.8–85.9 |
| Reverse hybrid | ||||||
| Denmark | 807 | 52 | NA | NA | NA | NA |
| Sweden | 9,579 | 306 | 91.8 | 90.0–93.3 | NA | NA |
| Norway | 9,084 | 265 | 92.9 | 91.2–94.2 | NA | NA |
| Finland | 2,686 | 214 | 87.4 | 85.4–89.2 | NA | NA |
NA: not available.